Medicine guide
Olysio
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Simeprevir
- Made by
- Janssen-Cilag International NV
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Olysio is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adult patients. For hepatitis C virus (HCV) genotype specific activity.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Janssen-Cilag International NV |
|---|---|
| Active substance | Simeprevir |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J05AE14 · Antibiotics, antivirals and antifungals taken into the body |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2014-05-14 |
| Last updated by the regulator | 2018-05-23 |
| EMA product number | EMEA/H/C/002777 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).